Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Nov 21:6:276-284.
doi: 10.5414/ALX02318E. eCollection 2022.

Adherence in allergen immunotherapy: Current situation and future implications

Francesca Gehrt  1 , Qingqing Xu  2   3 , Ilaria Baiardini  4   5 , Giorgio Walter Canonica  4   5 , Oliver Pfaar  1
Affiliations
Review

Adherence in allergen immunotherapy: Current situation and future implications

Francesca Gehrt et al. Allergol Select. .

Abstract

Allergen immunotherapy (AIT) is the only disease-modifying treatment in allergy. However clinical trials as well as real-life studies revealed poor treatment adherence. This article is intended to provide an overview of the current literature of the last 10 years, to outline reasons for poor treatment adherence in AIT and to provide possible solutions for improving adherence.

Keywords: adherence; allergen immunotherapy; persistence; subcutaneous; sublingual.

PubMed Disclaimer

References

    1. Weinberg EG The WAO white book on allergy 2011 – 2012. Current Allergy and Clinical Immunology. 2011; 24: 156–157.
    1. Egert-Schmidt AM Kolbe JM Mussler S Thum-Oltmer S Patients’ compliance with different administration routes for allergen immunotherapy in Germany. Patient Prefer Adherence. 2014; 8: 1475–1481. - PMC - PubMed
    1. Pfaar O Agache I de Blay F Bonini S Chaker AM Durham SR Gawlik R Hellings PW Jutel M Kleine-Tebbe J Klimek L Kopp MV Nandy A Rabin RL van Ree R Renz H Roberts G Salapatek AM Schmidt-Weber CB Shamji MH Perspectives in allergen immunotherapy: 2019 and beyond. Allergy. 2019; 74: 3–25. - PubMed
    1. Pfaar O Bousquet J Durham SR Kleine-Tebbe J Larché M Roberts G One hundred and ten years of Allergen Immunotherapy: A journey from empiric observation to evidence. Allergy. 2021; 77: 454–468. - PubMed
    1. Burks AW Calderon MA Casale T Cox L Demoly P Jutel M Nelson H Akdis CA Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report. J Allergy Clin Immunol. 2013; 131: 1288–96.e3. - PubMed

LinkOut - more resources